Use Options For a Chance To Buy KERX at a 31% Discount

Looking back to 2 days ago, Keryx Biopharmaceuticals (KERX) priced a 6,900,000 share secondary stock offering at $14.50 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Friday, the stock is now 5.1% higher than the offering price..